Recce Pharmaceuticals Ltd (ASX: RCE) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs.
Bristol-Myers Squibb
275 followers
Astellas Pharma
45 followers
NYU Langone Health
34 followers
West Pharmaceutical Services
10 followers
Curia Global
7 followers
AbbVie
294 followers
Navitus Health
6 followers
Xeris Pharmaceuticals
3 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies